These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7446303)

  • 1. Dihydrofolate reductases as targets for inhibitors.
    Hitchings GH; Smith SL
    Adv Enzyme Regul; 1980; 18():349-71. PubMed ID: 7446303
    [No Abstract]   [Full Text] [Related]  

  • 2. The gel-filtration behaviour of dihydrofolate reductases from culture forms of trypanosomatids.
    Gutteridge WE; Jaffe JJ; McCormack JJ
    Biochim Biophys Acta; 1969; 191(3):753-5. PubMed ID: 5363996
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids.
    Hynes JB; Eason DE; Garrett CM; Colvin PL
    J Med Chem; 1977 Apr; 20(4):588-91. PubMed ID: 850245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of bacterial and mammalian dihydrofolate reductases.
    Stone D
    Biochem Soc Trans; 1981 Aug; 9(4):271-3. PubMed ID: 7262441
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of brodimoprim as an inhibitor of dihydrofolate reductases.
    Then RL; Hermann F
    Chemotherapy; 1984; 30(1):18-25. PubMed ID: 6363003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinazolines as inhibitors of dihydrofolate reductase. 1.
    Ashton WT; Walker FC; Hynes JB
    J Med Chem; 1973 Jun; 16(6):694-7. PubMed ID: 4715004
    [No Abstract]   [Full Text] [Related]  

  • 7. Presence and properties of dihydrofolate reductases in Trypanosomatid flagellate.
    Gutteridge WE; Jaffe JJ; McCormack JJ
    Trans R Soc Trop Med Hyg; 1969; 63(1):119. PubMed ID: 5789067
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases.
    da Cunha EF; de Castro Ramalho T; Bicca de Alencastro R; Maia ER
    J Biomol Struct Dyn; 2004 Oct; 22(2):119-30. PubMed ID: 15317473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential folic acid antagonists. 4. Synthesis and dihydrofolate reductase inhibitory activities of 2,4,6-triamino-5-arylazopyrimidines.
    Chatterjee SS; Garrison DR; Kaprove R; Moran JF; Triggle AM; Triggle DJ; Wayne A
    J Med Chem; 1971 Jun; 14(6):499-501. PubMed ID: 5091964
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of tomizine (4-methoxy-6-aminopyrimido (4,5-b) (1,4)thiazine hydrochloride) on the physicochemical properties of the enzymes of folic acid metabolism--dihydrofolate reductase and nonspecific dihydrofolate reductase].
    Andreeva NA; Tongur AM; Kuznetsov BA; Shumakovoch GP; Gadzhieva AG
    Izv Akad Nauk SSSR Biol; 1983; (5):766-70. PubMed ID: 6630719
    [No Abstract]   [Full Text] [Related]  

  • 11. Species differences among dihydrofolate reductases as a basis for chemotherapy.
    Hitchings GH
    Postgrad Med J; 1969 Nov; 45():Suppl:7-10. PubMed ID: 5361314
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of coenzyme A inhibition of dihydrofolate reductase.
    Mita M; Yasumasu I
    Int J Biochem; 1982; 14(7):549-51. PubMed ID: 7106354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General distance geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors.
    Ghose AK; Crippen GM
    J Med Chem; 1984 Jul; 27(7):901-14. PubMed ID: 6737433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible enzyme inhibitors. CLXXVII. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines. II.
    Baker BR; Vermeulen NM
    J Med Chem; 1970 Nov; 13(6):1154-60. PubMed ID: 5479856
    [No Abstract]   [Full Text] [Related]  

  • 15. Irreversible enzyme inhibitors. CLXXIX. Active-site-directed irreversible enzyme inhibitors of dihydrofolate reductase from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with oxyamide bridges to a terminal sulfonyl fluoride.
    Baker BR; Ashton WT
    J Med Chem; 1970 Nov; 13(6):1165-70. PubMed ID: 5479858
    [No Abstract]   [Full Text] [Related]  

  • 16. Bicyclic conformationally restricted analogs of nonclassical pyrido[2,3-d] pyrimidines as potential inhibitors of dihydrofolate reductases.
    Gangjee A; Vasudevan A; Queener SF
    Adv Exp Med Biol; 1993; 338():449-52. PubMed ID: 8304156
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible enzyme inhibitors. 178. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with a terminal sulfonyl fluoride.
    Baker BR; Ashton WT
    J Med Chem; 1970 Nov; 13(6):1161-5. PubMed ID: 5479857
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutational 'hot-spots' in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: sequence and structural comparison.
    Volpato JP; Pelletier JN
    Drug Resist Updat; 2009; 12(1-2):28-41. PubMed ID: 19272832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermodynamic study of folate analogue binding to dihydrofolate reductases from different species.
    Sasso S; Gilli R; Lopez C; Sari JC; Briand C
    Adv Exp Med Biol; 1993; 338():521-4. PubMed ID: 8304171
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative properties of schistosomal and filarial dihydrofolate reductases.
    Jaffe JJ; McCormack JJ; Meymarian E
    Biochem Pharmacol; 1972 Mar; 21(5):719-31. PubMed ID: 4401788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.